Forte Biosciences Valuation
| FBRX Stock | USD 16.08 0.08 0.50% |
At this time, the firm appears to be overvalued. Forte Biosciences shows a prevailing Real Value of $9.23 per share. The current price of the firm is $16.08. Our model computes the value of Forte Biosciences from reviewing the firm fundamentals such as Shares Owned By Insiders of 10.94 %, current valuation of 7.03 M, and Shares Owned By Institutions of 54.05 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Forte Biosciences' valuation include:
Price Book 2.4974 | Enterprise Value 7 M | Enterprise Value Ebitda 1.872 |
Overvalued
Today
Please note that Forte Biosciences' price fluctuation is very risky at this time. Calculation of the real value of Forte Biosciences is based on 3 months time horizon. Increasing Forte Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Forte Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Forte Stock. However, Forte Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.08 | Real 9.23 | Target 3.5 | Hype 15.78 | Naive 20.15 |
The intrinsic value of Forte Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Forte Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Forte Biosciences helps investors to forecast how Forte stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Forte Biosciences more accurately as focusing exclusively on Forte Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Forte Biosciences' intrinsic value based on its ongoing forecasts of Forte Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Forte Biosciences' closest peers.
Forte Biosciences Cash |
|
Forte Valuation Trend
Analysing the historical paterns of Forte Biosciences' enterprise value and its market capitalization is a good way to estimate and gauge the value of Forte Biosciences over time and is usually enough for investors to make rational market timing decisions.
Forte Biosciences Total Value Analysis
Forte Biosciences is currently projected to have valuation of 7.03 M with market capitalization of 23.39 M, debt of 3.67 M, and cash on hands of 38.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Forte Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.03 M | 23.39 M | 3.67 M | 38.55 M |
Forte Biosciences Asset Utilization
One of the ways to look at asset utilization of Forte is to check how much profit was generated for every dollar of assets it reports. Forte Biosciences shows a negative utilization of assets of -0.81 percent, losing $0.008125 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Forte Biosciences shows how discouraging it operates for each dollar spent on its assets.Forte Biosciences Ownership Allocation
The market capitalization of Forte Biosciences is $23.39 Million. Over half of Forte Biosciences' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Forte Biosciences Profitability Analysis
Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0.About Forte Biosciences Valuation
Our relative valuation model uses a comparative analysis of Forte Biosciences. We calculate exposure to Forte Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Forte Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -8.1 K | -7.7 K | |
| Pretax Profit Margin | (2.36) | (2.48) | |
| Operating Profit Margin | (2.29) | (2.40) | |
| Net Loss | (2.44) | (2.57) |
Forte Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.3 M |
Forte Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Forte Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Forte we look at many different elements of the entity such as Forte's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Forte Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Forte Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Forte Biosciences' worth.Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.